Muthusamy Shanmugam sold $8.8M of ANIP
HEAD OF R&D, COO-NOVITIUM OPS at ANI PHARMACEUTICALS INC. 100,000 shares at an average of $88.25, traded Aug 14, 2025, filed Aug 18, 2025.
Score components
- +20RoleCOO
- +25Trade size$8.8M at market
- +5Share of holdings soldSold 16% of holdings
- +15Cluster13 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001870913-25-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 14, 2025 | SOpen-market sale Common Stockindirect: Held by Esjay LLC | -47,010 | $89.48 | $4.2M | 584,910 | Aug 18, 2025 |
| Aug 15, 2025 | SOpen-market sale Common Stockindirect: Held by Esjay LLC | -52,990 | $87.15 | $4.6M | 531,920 | Aug 18, 2025 |
Related signals
Other insiders at ANI PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $208k 2,850 shares | -2% | |
| 36Weak | ANI PHARMACEUTICALS INC | Nikhil Lalwani PRESIDENT & CEO | $383k 5,400 shares | -2% | |
| 18Weak | ANI PHARMACEUTICALS INC | Jeanne Thoma director | $72k 1,000 shares | -4% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $35k 500 shares | -1% | |
| 29Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $207k 2,850 shares | -2% | |
| 21Weak | ANI PHARMACEUTICALS INC | Krista Davis SVP, CHIEF HR OFFICER | $134k 1,622 shares | -3% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $33k 400 shares | -1% | |
| 41Moderate | ANI PHARMACEUTICALS INC | Renee P Tannenbaum director | $146k 1,800 shares | -7% | |
| 57Moderate | ANI PHARMACEUTICALS INC | Patrick D Walsh director | $751k 8,643 shares | -12% | |
| 55Moderate | ANI PHARMACEUTICALS INC | Chad Gassert SVP - CORP. DEV. & STRATEGY | $1.3M 14,736 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.